• ikhasi - 1

Ikhithi yokuhlola iTyphoid yezokwelapha, isinyathelo esisodwa sekhasethi lokuhlola ngokushesha

Incazelo emfushane:


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Ukuzwela Komtholampilo, Ukucacisa kanye Nokunemba

I-Influenza A+B Antigen Rapid Test ihloliwe uma iqhathaniswa ne-RT-PCR.539 ama-nasopharyngeal swabs kanye nama-oropharyngeal swabs ahlolwe ngokuhlolwa okushesha komkhuhlane we-A+B.

Izinto

Ukugxila

Izinto

Ukugxila

Isifutho Amakhala

15% v/v

IHemoglobin

10% v/v

Mucin

0.5 % w/v

I-Mupirocin

10 mg/mL

Amathonsi Amakhala

15% v/v

Ukugeza umlomo

/

I-Chloraseptic

1.5 mg/mL

Levofloxacin

40 ug/mL

I-Oseltamivir

2ug/mL

I-Ribavirin

0.2ug/mL

I-Fluticasone propionate

5% v/v

I-Ceftriaxone

800 ug/mL

I-Tobramycin

4ug/mL

I-Saline Nasal Spray

10% v/v

Ngomkhuhlane A

Indlela

I-RT-PCR

Isamba Semiphumela

Ukuhlolwa Okusheshayo Komkhuhlane A+B

Imiphumela

Okuhle

Okubi

Okuhle

116

1

117

Okubi

5

417

422

Isamba Semiphumela

121

418

539

Ukuzwela komtholampilo: 95.87% (95% CI: 90.69% ~ 98.22%)
Ukucaciswa komtholampilo:99.76% (95% CI: 98.66%~99.96%)
Isamba sezinga lokuqondana:98.89% (95% CI: 97.59%~99.49%).

Ngomkhuhlane B:

Indlela

I-RT-PCR

Isamba Semiphumela

Ukuhlolwa Okusheshayo Komkhuhlane A+B

Imiphumela

Okuhle

Okubi

Okuhle

97

1

98

Okubi

6

435

441

Isamba Semiphumela

103

436

539

Ukuzwela komtholampilo: 94.17% (95% CI: 87.87% ~ 97.30%)
Ukucaciswa komtholampilo:99.77% (95% CI: 98.71%~99.96%)
Isamba sezinga lokuqondana:98.70% (95% CI: 97.34%~99.37%).

Ukuzwela Kokuhlaziya/LOD

 img-1 I-Hangzhou Aichek Medical Technology CO., Ltd.

Jinxing Cun, Yuhang Community, Yuhang

Isifunda (Idolobha Elizayo Sci-Tech), i-Hangzhou,

Zhejiang, PR China

 img-2 I-SUNGO Europe BV

I-Olympisch Stadion 24, 1076DE Amsterdam, Netherlands

Umkhawulo wokutholwa (i-LOD) uhlonzwe ngokuhlola ukugxila okuhlukene kwegciwane lomkhuhlane A kanye negciwane lomkhuhlane B ku-Influenza A+B Antigen Rapid Test.Ukugxila okuhlonzwe njengamazinga e-LOD ahloliwe kubhalwe ngezansi.
Umkhuhlane A (H3N2): 5×103 TCID50/mL
Umkhuhlane A (H1N1): 2.5×103 TCID50/mL
Umkhuhlane A (H1N1 pdm09): 2.5×103 TCID50/mL
Umkhuhlane B (Yamagata): 3.5×103 TCID50/mL
Umkhuhlane B (Victoria): 1.0×103 TCID50/mL

Ukucaciswa Kokuhlaziya (Ukuphinda Usebenze kabusha)

Ukuze kutholwe ukucaciswa kokuhlaziya Kokuhlolwa Okusheshayo Komkhuhlane A+B, ama-microorganisms ambalwa e-commensal noma e-pathogenic angase abe khona endaweni yokuphefumula ephezulu ahlolwe.
Ama-specimens amahle noma angalungile afakwe kulawa magciwane ahlolwa ekugxilweni kwe-106 TCID50/mL, okuhlanganisa i-SARS-CoV-2, i-Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumoviruse, I-Revrunavirus syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.Akukho ukusabela okuphambene okubonwe nge-Influenza A+B Antigen Rapid Test.

UKUSETSHENZISWA OKUHLOSIWE

Ukuhlolwa Okusheshayo Komkhuhlane A+B I-Antigen Rapid Test iyi-assay yokugeleza yangemuva ehloselwe ukuthola ikhwalithi yomkhuhlane A kanye nama-antigens omkhuhlane B ku-nasopharyngeal swab kanye ne-oropharyngeal swab.

Inzuzo Yenkampani

1. Umkhiqizi Ochwepheshe, inkampani “enkulu” esezingeni likazwelonke
2.Letha izimpahla njengesicelo se-oda
3.ISO13485, CE, Lungiselela imibhalo ehlukahlukene yokuthumela
4.Phendula imibuzo yamakhasimende phakathi namahora angama-24


  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona